FDAnews Publication NEW Edition: Guide to International Pharma Regulation — 2014 Edition

FDAnews’ editors monitor and report on regulatory developments affecting drug production in more than 45 nations around the world. They’ve compiled more than 150 reports highlighting changes from the past year that will keep drugmakers growing in international markets.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Guide to International Pharma Regulations - 2014 Edition

Guide to International Pharma Regulations - 2014 Edition

Falls Church, VA (PRWEB) February 12, 2014

Guide to International Pharma Regulation — 2014 Edition
**FDAnews Publication**http://www.fdanews.com/IntlPharmaRegs2014

In drug manufacturing, success means staying abreast of regulatory changes from Australia to Zimbabwe ... and beyond.

Impossible? Not at all. Announcing publication of the 2014 edition of the Guide to International Pharma Regulation.

It’s the one-stop authority for quick, accurate answers to all questions on the fastest moving regulatory topics drugmakers face:

  •     Changes in inspection practices
  •     Quality manufacturing standards
  •     New patent regulations
  •     Sunshine and transparency regulations
  •     Tough new bribery laws
  •     Labeling and marketing regulations
  •     Changing pharmacovigilance requirements
  •     Anti-counterfeiting measures
  •     Orphan drug regs
  •     And dozens more key topics in drug regulation worldwide

International compliance is no longer simply a matter of playing by the same old rules.

There’s been a dramatic increase in foreign inspections. Many countries are collaborating via joint inspections and confidentiality agreements that permit sharing of inspection results. And in many countries, drug safety concerns are prompting new requirements. Drugmakers learn the new rules of the game or cede the playing field to competitors.

That’s where the FDAnews Guide to International Pharma Regulation — 2014 Edition comes in. Our editors monitor and report on regulatory developments affecting drug production in more than 45 nations around the world. They’ve compiled more than 150 reports highlighting changes from the past year that will keep drugmakers growing in international markets.

Readers will turn to this total regulatory reference time and again in the months ahead. It will become the one-stop source for:

  •     Coverage of the EU, Asia, Latin America, the Middle East, North America and Australia/Pacific
  •     Essential international regulatory changes from all of 2013
  •     Comprehensive summaries and explanations of the changes
  •     Key regulations — full-text printouts
  •     And much more!

To compete internationally, drugmakers must comply internationally. It’s a lesson the competition has learned. Don’t get left behind.

Publication Details:
Guide to International Pharma Regulation — 2014 Edition
**FDAnews Publication**
http://www.fdanews.com/IntlPharmaRegs2014

Format: Print or CD
Price: $387

Easy Ways to Order:
Online:     http://www.fdanews.com/IntlPharmaRegs2014
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.